Sep 11, 2017 20:05 pm UTC| Business
MRG-201 was nebulized and delivered to the lungs via inhalation in rodentsAdministration of aerosolized microRNA-29 mimic was observed to result in down-regulation of pharmacodynamic and mechanistic biomarkers important in...
Sep 11, 2017 20:05 pm UTC| Business
JERSEY CITY, N.J., Sept. 11, 2017 -- SITO Mobile Ltd. (NASDAQ:SITO) (“SITO”), an insights-driven consumer behavior and location sciences company, today announced the appointment of two new members to its Board of...
Sep 11, 2017 20:05 pm UTC| Business
-- Avid Bioservices Records Revenues of $27 Million in the First Quarter of FY2018 -- -- Roger Lias, Ph.D., Appointed President of Avid Bioservices as Company Continues Transition to a CDMO Focused Business...
Portola Pharmaceuticals Announces Proposed Offering of Common Stock
Sep 11, 2017 20:01 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Sept. 11, 2017 -- Portola Pharmaceuticals, Inc.® (Nasdaq:PTLA) today announced plans to offer, subject to market and other conditions, $300 million of its common stock in an underwritten...
BioCryst Pharmaceuticals Commences Public Offering of Common Stock
Sep 11, 2017 20:01 pm UTC| Business
RESEARCH TRIANGLE PARK, N.C., Sept. 11, 2017 -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) a biotechnology company focused on the development and commercialization of treatments for rare and infectious diseases,...
Sep 11, 2017 20:01 pm UTC| Business
Executing Plan to File NDA for Durasert Three-year Treatment for Posterior Segment Uveitis Conference Call and Webcast Today, September 11th, at 4:30 p.m. ET WATERTOWN, Mass., Sept. 11, 2017 -- pSivida Corp....
Sep 11, 2017 20:01 pm UTC| Business
ATLANTA, Sept. 11, 2017 -- Alimera Sciences, Inc. (NASDAQ:ALIM) (Alimera), a leader in commercialization and development of prescription ophthalmic pharmaceuticals, announced that due to the severe tropical storm...